A 34-year-old man presented to the accident and emergency (A&E) department having taken a mixed overdose at approximately midday. This included 140 mg diazepam, 120 mg temazepam, 240 mg citalopram, 500 mL anti-freeze solution and an unknown quantity of perindopril, doxazosin, amlodipine and co-codamol (codeine and paracetamol).
Case report
A 34-year-old man presented to the accident and emergency (A&E) department having taken a mixed overdose at approximately midday. This included 140 mg diazepam, 120 mg temazepam, 240 mg citalopram, 500 mL anti-freeze solution and an unknown quantity of perindopril, doxazosin, amlodipine and co-codamol (codeine and paracetamol).
On arrival, at 13:00, the ambulance crew recorded his blood pressure (BP) at 68/42 mm Hg, which improved to 105/66 mm Hg following the administration of 1 litre of 0.9% sodium chloride. The initial Glasgow Coma Score (GCS) was 5-6/15 (E1 V1-2 M3), the heart rate was 126 beats per minute and the SpO 2 86% on room air, improving to 100% with highflow oxygen.
In A&E, he remained hypotensive (BP 69/32), hypoxic and deeply unconscious (the GCS deteriorated to 3) and he was intubated following the administration of lidocaine spray to the vocal cords.
Laboratory results of note included a potassium level of 2.7 mmol/L, a rising creatinine from 90 to 115 µmol/L, metabolic acidaemia (pH 7.1, PaO 2 16.02 kPa, PaCO 2 4.0 kPa, bicarbonate 9.3 mmol/L, base excess -18.9 mmol/L) with a raised anion gap, 20.8 mmol/L, lactate 4 mmol/L, osmolar gap 61 mmol/L, alcohol level <1 mg/100mL and calcium oxalate crystaluria.
He was transferred to the intensive care unit and was managed with vasopressors, inotropes, fluid boluses and electrolyte replacement. As there was evidence of ethylene glycol poisoning (with a raised osmolar gap and raised anion gap metabolic acidosis with calcium oxalate crystalluria), he was commenced on alcohol and 8.4% sodium bicarbonate infusions and continuous renal replacement therapy (CRRT) was instituted.
Despite this maximal management, the patient' s hypotension was resistant to a combination of adrenaline, noradrenaline and vasopressin. The lactate level increased (14.4 mmol/L), the partially compensated metabolic acidosis continued and the patient had a borderline urine output. The GCS remained at 3 despite alcohol being the only sedative drug given. Due to problems with dialysis filters clotting, CRRT was interrupted and up to 2300 hours, he received approximately 90 minutes of dialysis in total.
Using examples from previous case reports 1-3 on the management of mixed overdose with neurological and cardiovascular compromise, the patient was given 20% lipid emulsion (Intralipid TM ) at 23:00 according to the AAGBI guidelines (2010) for the management of local anaesthetic toxicity, 4 ie, three 1.5 mL/kg boluses were given followed by an infusion of 15 mL/kg/hr to a total of approximately 12 mL/kg (1000 mL).
Sedation was started at approximately 23:30 as his GCS improved, with resulting combative behaviour. His inotrope and vasopressor requirements decreased; adrenaline was discontinued at 01:00 and vasopressin at 06:00. By 06:00 his metabolic acidosis had improved (pH 7.36, pO 2 10.93 kPa, pCO 2 He continued to improve (see Figure 1) and CRRT was discontinued after 36 hours with the alcohol infusion stopping at 06:00 on day three post-overdose. He was extubated on day three and noradrenaline and sedation infusions were discontinued at the same time. Renal function improved to near-baseline prior to discharge with a creatinine of 132 µmol/L, having peaked at 542 µmol/L on day 5. He was neurologically intact and discharged home on day 12.
Discussion
Previous case reports have demonstrated a clinical improvement following the administration of Intralipid in cases of mixed overdose. [1] [2] [3] There are several suggested mechanisms of action of Intralipid as a drug antidote. It is thought to act as a lipid sink, binding fat-soluble molecules. It may also act through the provision of a direct myocardial energy source in the form of free fatty acids that are produced from the breakdown of the lipid emulsion. In addition, these free fatty acids directly activate voltage-gated calcium channels within the myocardium, thereby increasing intracellular calcium concentration. 5 In this case, we believe the improvement in consciousness and rapid decrease in inotropic and vasopressor support following the administration of Intralipid was the result of reduced plasma levels of benzodiazepines and antihypertensives, all of which are lipid soluble and potentially bound by Intralipid. While ethylene glycol is lipid soluble, its metabolites are not, therefore the effect of Intralipid may be limited in managing ethylene glycol overdose.
Some difficulties were encountered during the management of this patient. Following the administration of Intralipid, we were unable to obtain biochemistry results for approximately 12 hours, with results from the haematology lab affected for a shorter time, due to the lipid load in the blood. Thus, monitoring alcohol levels to gauge the effectiveness/safety of the alcohol infusion administered for ethylene glycol overdose was not possible. Samples were processed in the blood gas analyser, although it is possible that the accuracy of these results may also have been affected.
CRRT was largely interrupted due to difficulties with high access pressures that did not improve with changing the site of the dialysis line. The filters clotted six times throughout the 36-hour duration of CRRT, despite the use of heparin to prime the system and the use of an epoprostenol infusion.
Adverse effects described in the literature include alteration of diagnostic tests, allergic reactions and fat overload syndrome, producing hepatosplenomegaly, jaundice, seizures, fat embolism and coagulopathies. Pulmonary vasoconstriction may occur with associated hypoxia. In addition, augmentation of the inflammatory response has been reported. Despite an extensive list of possible risks, lipid emulsion appears well tolerated in clinical practice. 5, 6 Reports of difficulties in maintaining CRRT following administration of lipid emulsion appear elsewhere in the literature, presumably as a result of lipid molecules clogging the dialysis filters. 7 In summary, despite possible adverse effects, lipid emulsion appears to have an evolving role in the management of a patient with severe, life threatening overdose of lipid-soluble compounds.
